About us

With sponsors and CROs still on the hunt for emerging markets common with treatment-naive patients and good infrastructure, interest in the East and Africa is increasing.

Market analysis shows that in 2020, the budget allocated for research in the MENA region is expected to be around 1 billion dollars.

However, most institutions and health facilities in the Eastern countries and Africa regions in general are not well equipped and lack a proper research body to carry out research activities, and most doctors engage in phase IV trials without the institutions' involvement.

In line with the promised market development, CRUise is well positioned to cater to the needs of the ill-equipped/structured research bodies within the Eastern countries and Africa regions institutions. CRUise is part of ClinGroup holding.

It was established in 2013 by the devoted team of ClinServ in response to the continuous growth of the research market and the imperative need to find better ways to prevent, detect and treat patients.

The main objective of CRUise is to establish state of the art clinical research units (CRUs) within the institutions to provide the clinical research infrastructure to support investigators in the conduct of research.

CRUise abides by the highest quality standards to assist institutions to launch specialized CRUs through setting up all internal regulations and SOPs, staff training, and education through the alignment of the institutions with all required qualifications.